Press Release – Green Shoots Consulting

Avation Medical raises $22M+ from impressive line-up of new global investors to jump-start sales of the first closed-loop wearable neuromodulation technology for bladder treatment

Source: Avation Medical 01 Feb, 2024, 14:40 ET Avation’s Vivally® System, the only FDA-cleared, non-invasive, closed-loop, at-home wearable, changes the way urinary incontinence and urgency caused by overactive bladder syndrome is treated COLUMBUS, Ohio, Feb. 1, 2024 /PRNewswire/ — Avation Medical, an innovative neuromodulation and digital health company with a mission to make wearable peripheral […]

11 months ago

TURBINE RAISES €20 MILLION IN SERIES A FINANCING TO ADVANCE PROGRAMS & PARTNERSHIPS TOWARDS THE CLINIC WITH WORLD’S FIRST CANCER CELL SIMULATION PLATFORM

Source: Turbine 22 November 2022 TURBINE’S SIMULATED CELL PLATFORM IDENTIFIES NOVEL CANCER TREATMENTS AND HIGH UNMET NEED PATIENT GROUPS TO TARGET WHERE CURRENT EXPERIMENTAL OR COMPUTATIONAL APPROACHES FAIL TO SUCCEED LONDON, UK and BUDAPEST, Hungary — November 22, 2022 — Turbine, a company developing a cell behavior simulation platform today announced the closing of a […]

2 years ago

Verge Genomics Secures $98 Million in New Financing

SOURCE: Verge Genomics, BUSINESS WIRE December 16, 2021 06:30 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Verge Genomics, a tech-enabled drug discovery company pioneering the use of artificial intelligence (AI) and human data to develop new drugs, announced today it has closed an oversubscribed $98 million equity financing. The Series B financing was led by funds […]

3 years ago

Green Shoots Consulting, LLC Co-Sponsors White Paper on Real-World Evidence Ecosystem

An evolution of medical diagnostics, treatments, and services relies upon trusted vendors collectively developing “Digital DNA” – scaled medical datasets, diverse provider networks, and cutting-edge software applications STUART, Fla., Sept. 30, 2021 /PRNewswire/ — A new white paper co-sponsored by Green Shoots Consulting, LLC offers a unique lens into the emerging confluence of health care subsectors […]

3 years ago

McDermott Represents MERCK GHI in its investment in M2GEN

SOURCE: McDermott Will & Emery NEW YORK, March 23, 2021 /mwe.com/ — New York: International law firm McDermott Will & Emery represented Merck Global Health Innovation Fund (Merck GHI), a corporate healthcare venture capital fund, in its investment to recapitalize M2GEN, a leading oncology data and informatics platform focused on transforming cancer care. Clayton, Dubilier & […]

4 years ago

CD&R, Merck GHI, and McKesson Ventures Invest in Innovative Oncology Data and Informatics Company M2GEN

SOURCE: M2GEN, PRNewswire TAMPA, Fla. and NEW YORK, March 17, 2021 /PRNewswire/ — M2GEN today announced a significant new investment by Clayton, Dubilier & Rice (“CD&R”) funds, the Merck Global Health Innovation Fund (“Merck GHI”), and McKesson Ventures to recapitalize M2GEN, a leading oncology data and informatics platform focused on transforming cancer care, in partnership […]

4 years ago